Intrathecal baclofen

K K Jain MD (Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Originally released February 23, 1999; last updated January 17, 2017; expires January 17, 2020

Historical note and terminology

Baclofen has been the most widely used spasmolytic drug for the past 25 years. For about a decade, the intrathecal route has become the preferred mode of delivery of baclofen. This product was approved by the Food and Drug Administration in the United States in 1996.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.